Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / Pulsenmore, Ltd.

Approvalsnovel device granted (FDA De Novo)31 Oct 2025

Pulsenmore, Ltd.

31 Oct 2025: Novel device granted (FDA De Novo) · Pulsenmore ES. Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
31 Oct 2025
Device
Pulsenmore ES
Specialty
Radiology
Product Code
SGJ
Country
Israel
Location
Omer, Israel
Submitted
2024-12-11
Reference
DEN240074
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at Pulsenmore, Ltd.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Pulsenmore, Ltd. in our registers.

More in Radiology

De Novo Grants

See all

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.